Your browser doesn't support javascript.
loading
Newly diagnosed papillary craniopharyngioma with BRAF V600E mutation treated with single-agent selective BRAF inhibitor dabrafenib: a case report.
Rao, Mayank; Bhattacharjee, Meenakshi; Shepard, Scott; Hsu, Sigmund.
Affiliation
  • Rao M; The Vivian L. Smith Department of Neurosurgery, McGovern Medical School, The University of Texas Health Science Center at Houston, Houston, TX 77030, USA.
  • Bhattacharjee M; Department of Pathology and Laboratory Medicine, McGovern Medical School, The University of Texas Health Science Center at Houston, Houston, TX 77030, USA.
  • Shepard S; Department of Neurosurgery, Temple University School of Medicine, Philadelphia, PA 19140, USA.
  • Hsu S; The Vivian L. Smith Department of Neurosurgery, McGovern Medical School, The University of Texas Health Science Center at Houston, Houston, TX 77030, USA.
Oncotarget ; 10(57): 6038-6042, 2019 Oct 15.
Article in En | MEDLINE | ID: mdl-31666933
Key words
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Type of study: Diagnostic_studies Language: En Journal: Oncotarget Year: 2019 Type: Article Affiliation country: United States
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Type of study: Diagnostic_studies Language: En Journal: Oncotarget Year: 2019 Type: Article Affiliation country: United States